 |
|
|
|
Corporate Governances
|
Home Investor Relation Corporate Governances
|
|
|
Mr. BL Mittal, aged 51 years, is an FCA, FCS and FCM by education and has an experience of more than 20 years working as an entrepreneur and a social worker. His areas of work include digital platform of healthcare and financial services.
Mr. Ravi Kant Sharma, aged 45 years, is an FCA by education and is a seasoned entrepreneur with more than 20 years of demonstrated experience in scaling businesses from scratch. His areas of work include digital platform of healthcare and financial services.
Mr. Parimal Kumar Chattaraj, aged 75 years, holds a bachelor’s degree in science, a post graduate diploma in management and a bachelor’s degree in law. He has an experience of over 30 years working as an entrepreneur, management professional and legal advisor. His areas of work include contributing to business strategy, aligning employee skill to business, creating learning organisation, leadership development and organisation & HR solutions.
Mrs. Abha Mittal, aged 46 years, is a commerce graduate and holds a diploma in fashion designing. She has multiple years of experience working as a social worker and environmentalist. Her areas of work include NGOs and organic farming.
Mrs. Rupanjana De, aged 45 years, is an FCS and also holds post graduate qualifications in law and economics. She has over 19 years of experience working as a corporate legal professional. Her areas of work include company law, legal compliance, management, corporate governance, Corporate Social Responsibility and quality control.
Dr. Jayanta Nath Mukhopadhyaya, aged 59 years, is a Mechanical engineer from IIT - BHU, Varanasi, MBA from IIM Calcutta, UGC NET qualified and PhD in Economics from Jadavpur University. He has 35 years of professional experience. He has over 17 years of experience in industry working with leading companies like BOC India, IBP – Balmer Lawrie, Alghanim & SREI. He is presently Professor of Finance at Army Institute of Management and non-Executive Director at Vara Technology.
|
|
Audit Committee
The Audit Committee comprises of
Mr. Parimal Kumar Chattaraj-
Chairman
Mr. Ravi Kant Sharma- Member
Mrs. Rupanjana De- Member
Dr. J. N. Mukhopadhyaya- Member
Stakeholders Relationship Committee
TThe Stakeholders Relationship Committee comprises of
Mr. Parimal Kumar Chattaraj- Chairman
Mr. Banwari Lal Mittal- Member
Mrs. Rupanjana De- Member
Dr. J. N. Mukhopadhyaya- Member
Nomination and Remuneration Committee
The Nomination and Remuneration Committee comprises of
Mr. Parimal Kumar Chattaraj- Chairman
Mr. Ravi Kant Sharma- Member
Mrs. Rupanjana De- Member
Dr. J. N. Mukhopadhyaya- Member
Risk Management Committee
The Risk Management Committee comprises of
Mr. Banwari Lal Mittal- Chairman
Mr. Ravi Kant Sharma- Member
Mrs. Rupanjana De- Member
|
Press Release_09.03.2021 |
|
Intimation of Analyst / Institutional Investor meet_01.03.2021 |
|
Intimation of Analyst / Institutional Investor meet_22.02.2021 |
|
Investor Presentation – February, 2021 |
|
Newspaper publish UFR December, 2020 |
|
Intimation of BM Dec 2020 |
|
Intimation of Analyst / Institutional Investor meet_18.01.2021 |
|
Intimation of Analyst / Institutional Investor meet_31.12.2020 |
|
Intimation of Analyst / Institutional Investor meet_16.12.2020 |
|
Presentation of Quarterly Result at Stock Exchanges _SastaSundar |
|
Newspaper publish UFR September 2020 |
|
Intimation of BM Sept 2020 |
|
Press Release 30092020 |
|
Intimation under regulation 30_28.08.2020 |
|
Newspaper publish UFR June 2020 |
|
Newspaper publication to SE AGM |
|
Intimation of BM June 2020 |
|
Newspaper publish AFR March 2020 |
|
Intimation of BM March 2020_29.06.20 |
|
Newspaper publish UFR December 2020 |
|
Intimation of BM Dec 2019_14022020 |
|
Newspaper publish UFR 161219_30.09.19 |
|
Intimation of BM Sept 2019_13122019 |
|
Happymate Intimation to SE_17.07.2018 |
|
Intimation_Investors Meet_19.03.2018 |
|
Intimation_Amalgamation of SVL_13.01.2018 |
|
Outcome of Board Meeting 12.11.2018 |
|
Intimation of Board Meeting_12.11.2018 |
|
Outcome of Board Meeting_13.08.2018 |
|
Intimation of Board Meeting_13.08.2018 |
|
Outcome of Board Meeting_21.05.2018 |
|
Board Meeting Intimation_21.05.2018 |
|
Letter to SE_14.04.2018_GenuPathLabs |
|
Investors Presentation - February 2018 |
|
Investors Presentation - November 2017 |
|
Earnings Update Q2FY18 |
|
Outcome of Board Meeting 14.11.2017 |
|
Outcome of Board Meeting 10.08.2017 |
|
Letter to SE_04.09.17_GenuPathLabs |
|
Investor Presentation - May 2017 |
|
Intimation Analyst Meet_30.05.2017 |
|
Press Release_30.05.2017 |
|
Intimation to SE-27.05.2017 |
|
Intimation to SE-22.05.2017 |
|
Outcome of BM_26.05.2017 |
|
Intimation of Board Meeting_26.05.2017 |
|
Investor Update_February, 2017 |
|
Outcome of BM_14.02.2017 |
|
Intimation of BM_14.02.17 |
|
Reply of NSE Clarification- Outcome of Board meeting 5.1.2017 |
|
Reply of BSE Clarification- Outcome of Board meeting 5.1.2017 |
|
Outcome of Board Meeting_5.1.2017 |
|
Intimation of Board Meeting_05.01.2017 |
|
Press Release |
|
Investors Update December, 2016 |
|
Outcome of Circular resolution dated 27.08.2016 |
|
Investors Update_August 2016 |
|
Outcome of Board Meeting_26.05.2016 |
|
Intimation of Board Meeting_26.05.2016 |
|
Outcome of Board Meeting_19.04.2016 |
|
Intimation of Board Meeting_19.04.2016 |
|
Outcome of Board Meeting_09.02.2016 |
|
Intimation of Board Meeting_09.02.2016 |
|
Intimation of Board Meeting_10.11.2016 |
|
Outcome of Board Meeting_10.11.2016 |
|
Investors Presentation/ update- December, 2016 |
|
|
Terms and conditions of appointment of Independent Directors |
|
|
|
Code of Conduct |
|
|
Whistle Blower Policy |
|
|
Appointment Letter of Independent Director |
|
|
Quarter ended March, 2023 |
|
Quarter ended December, 2022 |
|
Quarter ended September, 2022 |
|
Quarter ended June, 2022 |
|
Quarter ended March, 2022 |
|
Quarter ended Dec, 2021 |
|
Quarter ended Sept, 2021 |
|
Quarter ended June, 2021 |
|
Quarter ended March, 2021 |
|
Quarter ended December, 2020 |
|
Quarter ended September, 2020 |
|
Quarter ended June, 2020 |
|
Quarter ended March, 2020 |
|
Quarter ended December, 2019 |
|
Quarter ended September, 2019 |
|
Quarter ended June, 2019 |
|
Quarter ended March, 2019 |
|
Quarter ended December, 2018 |
|
Quarter ended September, 2018 |
|
Quarter ended June, 2018 |
|
Quarter ended March, 2018 |
|
Quarter ended December, 2017 |
|
Quarter ended September, 2017 |
|
Quarter ended June, 2017 |
|
Quarter ended March, 2017 |
|
Quarter ended December, 2015 |
|
Quarter ended Septembar, 2015 |
|
Quarter ended June, 2015 |
|
Quarter ended March, 2015 |
|
Quarter ended December, 2014 |
|
Quarter ended September, 2014 |
|
Quarter ended June, 2014 |
|
Quarter ended March, 2014 |
|
Quarter ended December, 2013 |
|
Quarter ended June, 2013 |
|
Quarter ended September, 2013 |
|
Quarter ended March, 2013 |
|
Quarter ended December, 2012 |
|
Quarter ended September, 2012 |
|
Quarter ended June, 2012 |
|
Quarter ended March, 2012 |
|
Quarter ended December, 2011 |
|
Quarter ended September, 2011 |
|
Quarter ended June, 2011 |
|
Quarter ended March, 2011 |
|
|
|
Dividend Distribution Policy |
|
Code of Practices and Procedures for Fair Disclosure of UPSI |
|
Sexual Harrasment Policy |
|
Remuneration Policy |
|
Archival Policy |
|
Code of Conduct and Ethics |
|
Code of Conduct to regulate monitor and report trading by Insiders |
|
Code of Conduct |
|
Code of Fair Disclosure |
|
Familiarization Programme for Independent Director |
|
Policy for Determination of Material Subsidiary |
|
Policy on Materiality |
|
Policy on preservation of docs |
|
Related Party Transaction Policy |
|
Whistle blower policy |
|
|
Register of Director and KMP |
|
Register of contract |
|
|
|
|
|
|
|
|
|
 |
|
|